2025-2034 Opioid Use Disorder (OUD) Market Evolution: Disruptions, Innovations, and Untapped Opportunities

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Opioid Use Disorder (OUD) Market Through 2025?
The market encompassing opioid use disorder treatments has experienced swift escalation lately, projecting an increase from its 3.96 billion dollar valuation in 2024 to 4.37 billion dollars in 2025, reflecting a consistent annual expansion rate of 10.5 percent. This historical upward trajectory is largely ascribed to a rise in prescriptions issued, evolving methodologies in pain management, aggressive pharmaceutical promotion, and the societal stigma associated with addiction.

What's the Projected Size of the Global Opioid Use Disorder (OUD) Market by 2029?
Anticipation suggests the opioid use disorder (OUD) market will accelerate its expansion considerably over the coming years, reaching a valuation of $6.91 billion by 2029, propelled by a compound annual growth rate (CAGR) of 12.1%. This upward trajectory across the projection timeframe is largely fueled by increased regulatory actions, a heightened concentration on non-opioid pain relief methods, broader availability of therapeutic options, and various public health campaigns. Key developments shaping this period involve advancements in treatment technologies, personalized therapeutic strategies, the adoption of comprehensive care structures, growth in localized support networks, and increased efforts in early detection and preventative measures.

View the full report here:
https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

Top Growth Drivers in the Opioid Use Disorder (OUD) Industry: What's Accelerating the Market?
The escalating prevalence of opioid substance misuse is anticipated to act as a key catalyst for the expansion of the market addressing opioid use disorder (OUD) in the near future. Opioid addiction constitutes a diagnosable health problem marked by the uncontrollable and persistent consumption of opioids, resulting in detrimental physical consequences. Opioids are substances capable of inducing feelings of elation and alleviating discomfort; however, their sustained ingestion can foster tolerance, necessitating escalating dosages to attain prior effects, potentially culminating in an OUD diagnosis. To illustrate this trend, data from the US public health entity, the Centers for Disease Control and Prevention, indicated in March 2024 that the incidence of fatal overdoses involving synthetic opioids climbed by 4.1 percent, moving from a figure of 21.8 to 22.7 across the years 2021 and 2022; consequently, the increasing volume of individuals suffering from opioid addiction directly fuels the expansion trajectory of the OUD market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

What Trends Will Shape the Opioid Use Disorder (OUD) Market Through 2029 and Beyond?
Within the sphere of the opioid use disorder (OUD) market, the emergence of novel product development is a notable and increasingly favored pattern. Leading corporations engaged in the OUD sector are actively creating sophisticated offerings to secure or enhance their current standing. As an illustration of this, the United States Food and Drug Administration, which functions as a federal regulatory body in the US, greenlit Brixadi (buprenorphine) in May 2023; this is an extended-release injectable formulation intended for managing individuals diagnosed with moderate to severe opioid use disorder. Brixadi is supplied in two distinct dosing intervals: one administered every week, suitable for patients initiating therapy with a solitary dose of a transmucosal buprenorphine product or those already on this medication, and a second option delivered once monthly for patients already undergoing treatment with the active substance.

What Are the Main Segments in the Opioid Use Disorder (OUD) Market?
The opioid use disorder (oud)market covered in this report is segmented -

1) By Drug Type: Buprenorphine; Naltrexone; Methadone
2) By Route of Administration: Oral; Parenteral
3) By Age Group: 19 To 40; 41 To 60; 61 And Over
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies And Stores; Online Pharmacies

Subsegments:
1) By Buprenorphine: Suboxone; Buprenorphine Tablets; Buprenorphine Film
2) By Naltrexone: Naltrexone Tablets; Vivitrol
3) By Methadone: Methadone Tablets; Methadone Oral Solution

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12586&type=smp

Which Top Companies are Driving Growth in the Opioid Use Disorder (OUD) Market?
Major companies operating in the opioid use disorder (OUD) market include Pfizer Inc., Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Chiesi Pharmaceuticals S.p.A., Hikma Pharmaceuticals Plc., Mallinckrodt Pharmaceuticals, Indivior Plc., Purdue Pharma L.P, Alkermes Inc., Collegium Pharmaceutical Inc., Vanda Pharmaceuticals Inc., Camurus AB, Tris Pharma Inc., Mylan NV., Orexo US Inc., Zogenix Inc., Rhodes Pharmaceuticals L.P., Omeros Corporation, Braeburn Pharmaceuticals Inc., Adapt Pharma Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., AcelRx Pharmaceuticals Inc., KemPharm Inc.

Which Regions Will Dominate the Opioid Use Disorder (OUD) Market Through 2029?
North America was the largest region in the opioid use disorder (OUD) market in 2024. The regions covered in the opioid use disorder (OUD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12586

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.